TERRY CATO

• Lead development of strategy for specific new business development opportunities in addition to working with product, operations, technology, and commercial teams to evolve enterprise strategy for Patient Support Services + Patient Affordabilty (Hub, Specialty Reimbursement, Field Based Reimbursement Managers, Clinical, Free Goods (Bridge, PAP) segment
• Lead key client specific initiatives including launch program design, account management, transition services
• Key Opinion Leader and Go-to resource to help resolve complex Patient Support Service questions, strategies, and potential issues raised by commercial, operations, and product teams
• Develop and defend content related to strategy and tactics for patient support service opportunities (RFP responses and executive summaries, Bid Defense Slides, Technology Strategy).

Independent consultant, Patient Support Services strategy.

• Executive design and implementation lead for a top 4 Pharmaceutical client (initial bid response solutioning through program design and implementation)
• Led High Performing Business Development and Account Management Professionals who were tasked with managing multi-million-dollar, complex and highly matrixed pharmaceutical customers to expand product offerings and grow the CareMetx footprint within the customers ecosystem
• Identified opportunities to improve client service delivery, streamline processes, and leveraged new technology such as e reimbursement and contact center tools
• Collaborated with executive leadership team members on long-term strategic planning that ensured sustainable success for company
• Represented the voice of the client within the organization ensuring their needs and feedback were considered in technology and service offering roadmap.

• Coached, developed, and held program management team accountable for delivering areas of responsibility and exceeding client expectations.
• Delivered exceptional customer service by implementing best practices and fostering a culture of accountability within the organization.
• Championed innovation by encouraging cross-functional teams to pursue creative solutions to complex challenges.
• Moved operational teams to 100% remote during COVID

• Responsible for overall strategy, leadership, performance, and deployment of Alliance RX Walgreens Prime specialty provider field-based sales team
• Customer Experience lead ensuring satisfaction surveys were launched and completed, results communicated, and corrective action items taken
• Corporate Advocacy Lead, designing corporate advocacy strategy including fiscal year budgets, grant submission and approval processes, and developed and maintained key corporate advocacy relationships.

• Transition from Walgreens to AllianceRx Walgreens Prime ensuring rare disease program offerings, strategy, and client relationships were intact through changed organization structure
• Partnered with Marketing to introduce and train field based healthcare provider sales organization on newco messaging and program offerings
• Developed organizational patient advocacy budget and advocacy relationships including conference sponsorship and grant awards

• Responsible for overall strategy, sales and marketing, patient support programs, and advocacy relationships for organization's rare disorder programs for both centralized and local specialty pharmacies
• Led field based cystic fibrosis advocate team dedicated to supporting patients and providers across U.S
• Rare Disorder advocacy lead establishing and maintaining relationships with key rare disorder organizations (NORD, Global Genes, PHA, PFF, CFF, NHF, Cystinosis Foundation, Cure SMA, DMD, etc.) inclusive of annual organizational spend.

• Led PAH Pathways Management team (AD, Managers + 25 Case Managers) core internal call center (HUB) providing patient access and reimbursement support, Tracleer REMS provider certification and education, Tracleer REMS pharmacy certification for all US commercial products; reported directly into CEO, US
• Led and directed specialty pharmacy account team, which managed US distribution through specialty networks for oral, inhaled, and intravenous specialty products
• Achieved departmental goals by developing and implementing strategic plans and initiatives
• Led cross-functional teams to successfully launch new patient support service products, meeting deadlines and budgets.

• Led teams in developing, negotiating, and implementing Tracleer Risk Evaluation and Mitigation Strategy (REMS) in 2006, post commercial launch
• Coordinated specialty pharmacy activity and FDA correspondence for product recall, confirming all affected products replaced down to individual patient level
• Revised all specialty pharmacy distribution agreements and led efforts to establish & maintain fair market value for all US commercial product service offerings
• Achieved Circle of Excellence award, 2009.